NOTCH1 and cancer: For example, overexpressed miR-122 has been reported to reduce Hes1 and NOTCH1 in A549 stem cells, and by blocking the NOTCH1 pathway, miR-122 can reduce the resistance of A549 stem cells to gefitinib, and thereby suppressing cancer cell proliferation and migration [33].